Epirubicin may enhance the inhibition of hepatocellular carcinoma induced by iodine‐125 seeds through downregulating WNT pathway-Reference-Cited by-同舟云学术

Epirubicin may enhance the inhibition of hepatocellular carcinoma induced by iodine‐125 seeds through downregulating WNT pathway

Published:2022-12-04 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Tian Shilin¹^ORCID,Lu Yue²,Gao Haifeng³,Chen Zitong²,Niu Min⁴,Wang Changjun⁵,Liu Bin⁶⁷

Affiliation:

1. Department of Interventional MedicineShandong Cancer Hospital and InstituteShandong First Medical UniversityShandong Academy of Medical Sciences JinanChina

2. Cheeloo College of MedicineShandong University JinanChina

3. Department of OncologyDongying People's Hospital DongyingChina

4. Department of Gastrointestinal SurgeryTraditional Chinese Medicine Hospital of Jiyang County JinanChina

5. Department of RadiologyPeople's Hospital of Jiyang County JinanChina

6. Department of Interventional MedicineThe Second Hospital of Shandong University JinanChina

7. Interventional Oncology Institute of Shandong University JinanChina

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13873

Reference25 articles.

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

2. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection;Zhu ZX;Jpn J Clin Oncol,2016

3. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

4. Challenges in liver cancer and possible treatment approaches

5. [Intraoperative radiofrequency ablation and 125I therapy for preventing local recurrence in hepatocellular carcinoma after hepatectorny];Chen KY;Zhonghua Zhong Liu Za Zhi,2007